US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist
  • 5.570
  • +0.230+4.31%
Close Feb 14 16:00 ET
  • 5.571
  • +0.001+0.01%
Post 19:58 ET
1.70BMarket Cap-3.76P/E (TTM)

About Iovance Biotherapeutics Company

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007, and is headquartered in San Carlos, CA.

Company Profile

SymbolIOVA
Company NameIovance Biotherapeutics
Listing DateFeb 26, 2015
Founded2007
CEOMr. Frederick G. Vogt, J.D.,PhD
MarketNASDAQ
Employees557
Fiscal Year Ends12-31
Address825 Industrial Road,Suite 400,4th Floor
CitySan Carlos
ProvinceCalifornia
CountryUnited States of America
Zip Code94070
Phone1-650-260-7120
Websitehttp://www.iovance.com

Company Executives

  • Name
  • Position
  • Salary
  • Frederick G. Vogt, J.D.,PhD
  • Director, General Counsel, Interim Chief Executive Officer and President
  • 4.79M
  • Jean-Marc Bellemin
  • Chief Financial Officer and Principal Accounting Officer
  • 1.71M
  • Dr. Igor P. Bilinsky, PhD
  • Chief Operating Officer
  • 1.59M
  • Dr. Friedrich Graf Finckenstein
  • Chief Medical Officer
  • 1.77M
  • Dr. Iain D. Dukes, D.Phil.
  • Chairman of the Board
  • 933.48K
  • Dr. Athena Countouriotis, M.D.
  • Independent Director
  • 489.99K
  • Wendy L. Yarno, M.B.A.
  • Independent Director
  • 460.65K
  • Wayne P. Rothbaum
  • Independent Director
  • 240.00K
  • Dr. Michael Weiser,M.D.,PhD
  • Independent Director
  • 744.99K
  • Ryan D. Maynard
  • Independent Director
  • 489.99K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!